Patient Square Capital logo

Patient Square Capital

North America, California, United States, Menlo Park

Description

Patient Square Capital is a health care investment firm that will make investments by partnering with management teams whose products.

Investor Profile

Patient Square Capital has made 16 investments, with 4 in the past 12 months and 81% as lead.

Stage Focus

  • Series C (25%)
  • Private Equity (25%)
  • Series B (19%)
  • Series Unknown (13%)
  • Post Ipo Equity (13%)
  • Post Ipo Debt (6%)

Country Focus

  • United States (50%)
  • United Kingdom (25%)
  • Germany (6%)

Industry Focus

  • Health Care
  • Biotechnology
  • Biopharma
  • Life Science
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Finance
  • Financial Services
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Patient Square Capital frequently co-invest with?

Narya Capital
North America, Ohio, United States, Columbus
Co-Investments: 2
Bluebird Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 2
CAM Capital
North America, New York, United States, New York
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 3
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 2
Dexcel Pharma
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2
M&G Plc
Europe, England, United Kingdom, London
Co-Investments: 3

Which angels does Patient Square Capital often collaborate with?

JS
Europe, Germany
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Patient Square Capital?

LXE Hearing is a company focused on championing hearing wellness for everyone, everywhere.

Health CareMedical DeviceWellness
Private EquityMar 31, 2025
Amount Raised: $100,000,000
CorroHealth

Plano, Texas, United States

CorroHealth is a provider of revenue cycle management solutions for healthcare organizations, including health systems, and health plans.

AnalyticsFinanceFinancial ServicesFinTechHealth Care
Private EquityOct 24, 2024
Nuclera

Cambridge, Cambridgeshire, United Kingdom

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

BiotechnologyLife SciencePharmaceutical
Series COct 15, 2024
Amount Raised: $75,000,000

GondolaBio researches, develops and manufactures pharmaceutical products.

ManufacturingPharmaceutical
Series UnknownAug 16, 2024
Amount Raised: $300,000,000
Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo EquityJan 4, 2024
Amount Raised: $75,000,000
Apollo Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
Series CJan 2, 2024
Amount Raised: $33,500,000
Apollo Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
Series CSep 6, 2023
Amount Raised: $224,972,160

Elevage Medical Technologies offers support and growth for medical device companies by provding capital and expertise.

FinanceFinancial Services
Private EquityMay 1, 2023
Amount Raised: $300,000,000
Resolve BioSciences

Düsseldorf, Nordrhein-Westfalen, Germany

Resolve Biosciences is a biotechnology research company for molecular cartography.

BiotechnologyGeneticsHealth CareLife ScienceMedical
Series BOct 24, 2022
Amount Raised: $71,000,000
Eargo

San Jose, California, United States

Eargo is intended for people who have mild to moderate hearing loss.

Health CareMedical DeviceWearables
Post Ipo DebtJun 27, 2022
Amount Raised: $125,000,000